Compare Davita Inc (DVA) vs iShares 0 3 Month Treasury Bond ETF (SGOV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs iShares 0 3 Month Treasury Bond ETF — how do they compare? Davita Inc trades at $175.04 (market cap $11.28B), while iShares 0 3 Month Treasury Bond ETF trades at $100.51 (market cap $114.04B). The key difference: iShares 0 3 Month Treasury Bond ETF is far larger — about 10.1× Davita Inc's market cap, and Davita Inc is more actively traded (650,294 versus 19,563,576). Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and iShares 0 3 Month Treasury Bond ETF for 50 Days on average.
| DVA | SGOV | |
|---|---|---|
Market Cap | $11.28B | $114.04B |
Volume | 650,294 | 19,563,576 |
Sector | Health | Fixed Income |
52-Week High | $240.96 | $100.72 |
52-Week Low | $103.87 | $100.28 |
Typical Hold Time | 113 Days | 50 Days |
Enterprise Value | $24.00B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $177.02, down 1.87% on the day, showing mixed technical signals with a bearish moving average trend but neutral oscillators. Fundamentally, the company demonstrates strong earnings beats with Q2 2026 EPS of $4.02 exceeding expectations of $3.88, while revenue growth continues from $13.64B in 2025 to projected $14.0B in 2026. Recent developments include expanding value-based care partnerships with Humana, potentially benefiting over 10,000 Medicare Advantage members.
The outlook remains cautiously optimistic with 43% analyst buy ratings and a $235.67 consensus price target suggesting 33% upside. However, rising debt-to-asset ratios (65.55% in 2025) and margin pressures from Q2 2026 create headwinds. Key risks include regulatory changes in healthcare reimbursement and competitive pressures in dialysis services.
SGOV (iShares 0-3 Month Treasury Bond ETF) trades at $100.465 with minimal daily movement, reflecting its stable Treasury bill focus. The ETF shows bearish technical signals with 17 sell indicators versus 4 buys, though RSI levels suggest potential oversold conditions. Recent institutional selling by Envestnet Asset Management (-13.2% in Q2 2026) contrasts with consistent dividend distributions around $0.30-0.31 monthly.
SGOV provides stable income exposure to short-term US Treasuries amid rising bond yields, but faces headwinds from the ongoing bond market rout. The ETF's defensive positioning appeals to income-focused investors, though continued yield increases could pressure near-term performance. Current technical weakness suggests cautious entry points may emerge.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About iShares 0 3 Month Treasury Bond ETF
SGOV provides exposure to ultra-short-term U.S. Treasury bills with maturities of three months or less. It functions as a high-liquidity cash alternative, seeking to provide current income while maintaining a stable net asset value and minimal interest rate risk.
Read more on SGOV →
